NICE (TASE:NICE) Turns A Healthcare Contact Center Toward AI With CXone
Bailey Pemberton
Sat, August 29, 2026 at 9:45 PM GMT+5:30
3 min read
- NICE
+3.56%
NICE (TASE:NICE) reported that Bluecrest Health Intelligence has adopted its CXone platform to overhaul contact center operations using AI
The healthcare provider is using CXone to support a broad shift toward AI driven customer interactions and contact center processes
NICE highlighted operational efficiency, customer access, analytical insight, and resilience as key outcomes from the Bluecrest deployment
The case adds a high profile healthcare reference client for NICE at a time of rising interest in AI based contact center solutions
Readers looking for more ideas around the broader picks and shovels of AI infrastructure can continue with 56 AI infrastructure stocks
NICE provides AI powered cloud platforms for customer engagement and financial crime and compliance across multiple regions, so the Bluecrest deployment sits squarely in its core customer contact offering rather than an experimental side project
Beyond the headline: 1 risk and 2 things going right for NICE that every investor should see
NICE news shows the difference between AI buzz and measurable CX outcomes
The investment story for NICE rests on whether its AI powered CXone platform can drive recurring cloud adoption, not just headlines about automation. The Bluecrest Health Intelligence rollout goes straight to that Narrative by showing how deeply AI can be embedded in a large, complex contact center
“The rapid growth in demand for AI-driven customer experience solutions, manifested by 42% year-over-year growth in AI and self-service ARR and the upcoming integration of Cognigy’s conversational AI capabilities, provides visibility into sustained increases in high-margin, recurring cloud revenue and expanded ARPU…”
Read the full NICE narrativeto see the case behind these numbers
What the market may underplay here is how detailed outcome data from Bluecrest supports NICE’s AI monetization story. Concrete metrics around call handling time, interaction analytics and subscription uplift give NICE sales teams proof points when competing with vendors like Genesys and Five9 for large enterprise deals
At the same time, this kind of high touch deployment speaks to one of the Narrative risks, since complex international rollouts can be capital and reo flagged execution and integration challenges, so investors may want to see similar wins repeated across regions before assuming broad based traction
For readers, connecting case studies like this to a clear Narrative is what turns one client announcement into a decision about portfolio risk and opportunity To ensure you’re always in the loop on how the latest news impacts the investment narrative for NICE, head to the community page for NICE to never miss an update on the top community narratives
